STOCKSCREENR
Log In

NXL

NASDAQ

Nexalin Technology, Inc.

$0.41+0.00(+0.57%)Mkt Cap: $7.63M

Key Stats

Market Cap

$7.63M

P/E Ratio

-0.63

EPS

$-0.65

Dividend Yield

0.00%

52-Week Range

$0.37 — $2.57

Volume

75.86K

Avg Volume

339.65K

Beta

4.10

Valuation

P/E (TTM)

-0.63

Forward P/E

—

PEG Ratio

-0.07

P/S (TTM)

50.18

P/B (TTM)

1.58

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-2.07%

ROA (TTM)

-1.69%

ROIC

—

Gross Margin

-2.18%

Operating Margin

-56.41%

Net Margin

—

Debt/Equity

0.00

Current Ratio

13.47

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.44%

EPS Growth (5Y)

-0.36%

Sales Growth (3Y)

+2.59%

Sales Growth (5Y)

+1.51%

EPS Est (This Year)

$-0.39

EPS Est (Next Year)

—

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.24

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

18.65M

Float

15.93M

Free Float %

85.42%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2022-09-16

Employees

6

CEO

Mark White

Index Membership

—

Website

https://www.nexalin.com

Nexalin Technology, Inc. (NXL) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $7.63M, a P/E ratio of -0.63, NXL is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NXL against other stocks using dozens of fundamental and technical filters.

Similar Stocks

HSCS

HeartSciences Inc.

$2.65

-0.37%

$5.95M

BBLG

Bone Biologics Corporation

$1.24

+1.64%

$2.23M

AIDX

20/20 Biolabs, Inc. Common Stock

$2.16

-13.60%

$10.61M

PLSM

Pulsenmore Ltd. Ordinary Shares

$4.20

-2.33%

$27.31M

LFWD

Lifeward Ltd.

$7.56

+2.30%

$11.53M

VVOS

Vivos Therapeutics, Inc.

$1.32

+1.54%

$7.77M

Frequently Asked Questions

What is Nexalin Technology, Inc.'s P/E ratio?

Nexalin Technology, Inc. (NXL) has a trailing twelve-month (TTM) P/E ratio of -0.63. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Nexalin Technology, Inc. pay a dividend?

No, Nexalin Technology, Inc. (NXL) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Nexalin Technology, Inc.'s market cap?

Nexalin Technology, Inc. (NXL) has a market capitalization of $7.63 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.